Global and Region Novel Drug Delivery Systems in Cancer Therapy Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.

    The report details the trend, potential and market size of Novel Drug Delivery Systems in Cancer Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Novel Drug Delivery Systems in Cancer Therapymarket, defines the market attractiveness level of Novel Drug Delivery Systems in Cancer Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Novel Drug Delivery Systems in Cancer Therapy industry, describes the types of Novel Drug Delivery Systems in Cancer Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Novel Drug Delivery Systems in Cancer Therapy market and the development prospects and opportunities of Novel Drug Delivery Systems in Cancer Therapy industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Novel Drug Delivery Systems in Cancer Therapy market in Chapter 13.

    By Player:

    • Teva Pharmaceutical Industries Ltd

    • Merrimack Pharmaceuticals, Inc

    • GALEN

    • Johnson & Johnson Services, Inc

    • Samyang Biopharmaceuticals Corporation

    • Shire

    • Celgene Corporation

    • BTG

    • Spectrum Pharmaceuticals, Inc

    By Type:

    • Nanoparticles

    • Embolization Particles

    • Other

    By End-User:

    • Hospital

    • Clinic

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Novel Drug Delivery Systems in Cancer Therapy Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Novel Drug Delivery Systems in Cancer Therapy Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Novel Drug Delivery Systems in Cancer Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Novel Drug Delivery Systems in Cancer Therapy Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Novel Drug Delivery Systems in Cancer Therapy Market Analysis and Outlook to 2022

    • 7.1 Global Novel Drug Delivery Systems in Cancer Therapy Consumption (2017-2022)

    • 7.2 United States Novel Drug Delivery Systems in Cancer Therapy Consumption (2017-2022)

    • 7.3 Europe Novel Drug Delivery Systems in Cancer Therapy Consumption (2017-2022)

    • 7.4 China Novel Drug Delivery Systems in Cancer Therapy Consumption (2017-2022)

    • 7.5 Japan Novel Drug Delivery Systems in Cancer Therapy Consumption (2017-2022)

    • 7.6 India Novel Drug Delivery Systems in Cancer Therapy Consumption (2017-2022)

    • 7.7 South Korea Novel Drug Delivery Systems in Cancer Therapy Consumption (2017-2022)

    8 Region and Country-wise Novel Drug Delivery Systems in Cancer Therapy Market Analysis and Outlook to 2028

    • 8.1 Global Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast (2022-2028)

    • 8.2 United States Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast (2022-2028)

    • 8.3 Europe Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast (2022-2028)

    • 8.4 China Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast (2022-2028)

    • 8.5 Japan Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast (2022-2028)

    • 8.6 India Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast (2022-2028)

    • 8.7 South Korea Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast (2022-2028)

    9 Global Novel Drug Delivery Systems in Cancer Therapy Market Outlook by Types and Applications to 2022

    • 9.1 Global Novel Drug Delivery Systems in Cancer Therapy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Nanoparticles Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Embolization Particles Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Novel Drug Delivery Systems in Cancer Therapy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Novel Drug Delivery Systems in Cancer Therapy Market Outlook by Types and Applications to 2028

    • 10.1 Global Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Nanoparticles Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Embolization Particles Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Novel Drug Delivery Systems in Cancer Therapy Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Novel Drug Delivery Systems in Cancer Therapy Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Novel Drug Delivery Systems in Cancer Therapy Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Novel Drug Delivery Systems in Cancer Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Novel Drug Delivery Systems in Cancer Therapy Market Competitive Analysis

    • 14.1 Teva Pharmaceutical Industries Ltd

      • 14.1.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.1.2 Teva Pharmaceutical Industries Ltd Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Teva Pharmaceutical Industries Ltd Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • 14.2 Merrimack Pharmaceuticals, Inc

      • 14.2.1 Merrimack Pharmaceuticals, Inc Company Details

      • 14.2.2 Merrimack Pharmaceuticals, Inc Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merrimack Pharmaceuticals, Inc Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • 14.3 GALEN

      • 14.3.1 GALEN Company Details

      • 14.3.2 GALEN Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GALEN Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • 14.4 Johnson & Johnson Services, Inc

      • 14.4.1 Johnson & Johnson Services, Inc Company Details

      • 14.4.2 Johnson & Johnson Services, Inc Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Johnson & Johnson Services, Inc Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • 14.5 Samyang Biopharmaceuticals Corporation

      • 14.5.1 Samyang Biopharmaceuticals Corporation Company Details

      • 14.5.2 Samyang Biopharmaceuticals Corporation Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Samyang Biopharmaceuticals Corporation Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • 14.6 Shire

      • 14.6.1 Shire Company Details

      • 14.6.2 Shire Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Shire Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • 14.7 Celgene Corporation

      • 14.7.1 Celgene Corporation Company Details

      • 14.7.2 Celgene Corporation Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Celgene Corporation Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • 14.8 BTG

      • 14.8.1 BTG Company Details

      • 14.8.2 BTG Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 BTG Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • 14.9 Spectrum Pharmaceuticals, Inc

      • 14.9.1 Spectrum Pharmaceuticals, Inc Company Details

      • 14.9.2 Spectrum Pharmaceuticals, Inc Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Spectrum Pharmaceuticals, Inc Novel Drug Delivery Systems in Cancer Therapy Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Novel Drug Delivery Systems in Cancer Therapy

    • Figure Novel Drug Delivery Systems in Cancer Therapy Picture

    • Table Global Novel Drug Delivery Systems in Cancer Therapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Novel Drug Delivery Systems in Cancer Therapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Novel Drug Delivery Systems in Cancer Therapy Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Novel Drug Delivery Systems in Cancer Therapy Consumption by Country (2017-2022)

    • Figure United States Novel Drug Delivery Systems in Cancer Therapy Consumption and Growth Rate (2017-2022)

    • Table Europe Novel Drug Delivery Systems in Cancer Therapy Consumption and Growth Rate (2017-2022)

    • Figure China Novel Drug Delivery Systems in Cancer Therapy Consumption and Growth Rate (2017-2022)

    • Figure Japan Novel Drug Delivery Systems in Cancer Therapy Consumption and Growth Rate (2017-2022)

    • Figure India Novel Drug Delivery Systems in Cancer Therapy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Novel Drug Delivery Systems in Cancer Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast by Country (2022-2028)

    • Figure United States Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Novel Drug Delivery Systems in Cancer Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nanoparticles Consumption and Growth Rate (2017-2022)

    • Figure Global Embolization Particles Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Nanoparticles Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Embolization Particles Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Novel Drug Delivery Systems in Cancer Therapy Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Novel Drug Delivery Systems in Cancer Therapy Export by Region (Top 5 Countries) (2017-2028)

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • Table Merrimack Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Merrimack Pharmaceuticals, Inc Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merrimack Pharmaceuticals, Inc Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • Table GALEN (Foundation Year, Company Profile and etc.)

    • Table GALEN Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table GALEN Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • Table Johnson & Johnson Services, Inc (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Services, Inc Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Services, Inc Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • Table Samyang Biopharmaceuticals Corporation (Foundation Year, Company Profile and etc.)

    • Table Samyang Biopharmaceuticals Corporation Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Samyang Biopharmaceuticals Corporation Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • Table Shire (Foundation Year, Company Profile and etc.)

    • Table Shire Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • Table BTG (Foundation Year, Company Profile and etc.)

    • Table BTG Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table BTG Novel Drug Delivery Systems in Cancer Therapy Product and Service

    • Table Spectrum Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Spectrum Pharmaceuticals, Inc Novel Drug Delivery Systems in Cancer Therapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Spectrum Pharmaceuticals, Inc Novel Drug Delivery Systems in Cancer Therapy Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.